News

Stock markets have rallied after U.S. President Donald Trump announced a ceasefire in the Israel-Iran conflict, although the ...
Novo Nordisk has introduced Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce heart risks amid the country's growing obesity crisis. Listen to Story ...
Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock ...
Real-time index price for Nasdaq Composite (NASX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Vikrant Shrotriya, MD and Corporate VP of Novo Nordisk India, told CNBC-TV18 that Wegovy will be available in five dosage strengths. Here’s a look at its price and other key details. The first three ...
The drug is under distribution and will be in pharmacies by end of the month, said Vikrant Shrotriya, Novo Nordisk's India ...
Danish drugmaker Novo Nordisk officially launched its blockbuster weight-loss drug Wegovy on Tuesday as a once-a-week ...
The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations ...
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...
Rio Tinto, Hancock to Jointly Invest $1.6 Billion in Hope Downs 2 Project Rio Tinto said the development of the Hope Downs 2 project with Hancock Prospecting would involve two new pits that will churn ...